WHO - New Antibiotics Needed
Yesterday, WHO published a list of bacteria that are highly resistant and pose the greatest threat to human health. The list was created "to guide and promote research and development of new antibiotics" as part of an overall strategy to address the global antimicrobial resistance problem. I suspect this strategy also includes mention for resources targeting infection prevention and antimicrobial stewardship.
The creation of the list was a collaborative effort led by Prof Evelina Tacconelli and her colleagues in the ID Division at the University of Tübingen. They utilized decision-analytic techniques and many criteria including: "how deadly the infections they cause are; whether their treatment requires long hospital stays; how frequently they are resistant to existing antibiotics when people in communities catch them; how easily they spread between animals, from animals to humans, and from person to person; whether they can be prevented (e.g. through good hygiene and vaccination); how many treatment options remain; and whether new antibiotics to treat them are already in the R&D pipeline."
Nature has a nice discussion of this effort and places it into context with other existing initiatives. The "money" quote comes from Michael Gilmore: “The bottom line is that the economic model (for antibiotic development) doesn’t work.”
The creation of the list was a collaborative effort led by Prof Evelina Tacconelli and her colleagues in the ID Division at the University of Tübingen. They utilized decision-analytic techniques and many criteria including: "how deadly the infections they cause are; whether their treatment requires long hospital stays; how frequently they are resistant to existing antibiotics when people in communities catch them; how easily they spread between animals, from animals to humans, and from person to person; whether they can be prevented (e.g. through good hygiene and vaccination); how many treatment options remain; and whether new antibiotics to treat them are already in the R&D pipeline."
Nature has a nice discussion of this effort and places it into context with other existing initiatives. The "money" quote comes from Michael Gilmore: “The bottom line is that the economic model (for antibiotic development) doesn’t work.”
Comments
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.